...
首页> 外文期刊>Microbe: the news magazine of the American Society for Microbiology >Public Affairs Report:ASM Comments on the Proposed Addition of SARS-CoV to the List ofSelect Agents
【24h】

Public Affairs Report:ASM Comments on the Proposed Addition of SARS-CoV to the List ofSelect Agents

机译:公共事务报告:ASM关于将SARS-CoV建议添加到精选代理名单中的评论

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

On 2 September, ASM submittedcomments on the proposal to addSARS-associated coronavirus (SARSCoV) to the list of HHS select agentsand toxins, published in the July 13,2009, Federal Register, Vo. 74, No.132. The Centers for Disease Controland Prevention (CDC) states that it isproposing this action because (i) SARSCoV can cause significant mortality,especially in the elderly, (ii) the virushas the capability of easily beingtransmitted from human to human,(iii) there is currently no vaccine orantiviral approved for the preventionor treatment of infections caused bythe SARS CoV virus, and (iv) it hasbeen documented that the virus maypersist in the environment. The CDCstates that it has consulted with sub-ject matter experts from the CDC, theNational Institutes of Health, theFood and Drug Administration, andother federal agencies. The CDC rec-ognizes that there may be individualsand entities that are not currently reg-istered under the HHS Select AgentProgram who possess SARS CoV andwould be required to register withHHS should the proposal be finalized.
机译:9月2日,ASM提交了有关将SARS相关冠状病毒(SARSCoV)添加到HHS选择剂和毒素清单中的提议的评论,该提议发表于2009年7月13日,美国联邦公报。 74,第132号。疾病控制与预防中心(CDC)指出,正在提议采取此措施,因为(i)SARSCoV可能导致重大死亡,尤其是在老年人中;(ii)该病毒具有容易在人与人之间传播的能力,目前尚无批准用于预防或治疗由SARS冠状病毒引起的感染的疫苗或抗病毒药物,并且(iv)已证明该病毒可能在环境中持续存在。疾病预防控制中心说,它已经咨询了疾病预防控制中心,美国国立卫生研究院,食品和药物管理局以及其他联邦机构的主题专家。 CDC认识到,可能存在一些目前尚未在HHS选择代理人计划下注册的个人和实体,这些个人和实体拥有SARS CoV,并且如果最终确定建议,则需要在HHS进行注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号